pharmaphorum
MAY 24, 2021
Germany is lagging behind other countries in the adoption of digital health, including Spain and the US, according to a new survey carried out on behalf of drugmaker Fresenius. . The three-country poll found that Spain is way out in front, with over half of people asked responding that digital is already playing a major role in the networking of healthcare facilities, diagnosing illnesses and telemedicine.
Outsourcing Pharma
MAY 24, 2021
The owner of the pharmacy giant has announced plans to partner with various stakeholders in an effort to effect improvements across the trial ecosystem.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Times
MAY 28, 2021
Tremfya has already been recommended for NHS use to treat eligible patient with moderate-to-severe plaque psoriasis
Drug Patent Watch
MAY 27, 2021
Annual Drug Patent Expirations for EYSUVIS Eysuvis is a drug marketed by Kala Pharms Inc and is included in one NDA. There are eleven patents protecting this drug. EYSUVIS drug…. The post New patent for Kala Pharms drug EYSUVIS appeared first on DrugPatentWatch - Make Better Decisions.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
MAY 26, 2021
Remember the Care.data debacle? Now, a new move by NHS England to move the records of 55 million patients into a database that will be accessible by third-party companies is under fire by privacy campaigners, who claim it could be unlawful. . The new General Practice Data for Planning and Research (GPDPR) service was unveiled earlier this month by NHS Digital, which described it as a way to “improve” the collection of patient information that would allow better planning of healthcare
Pharma Marketing Network
MAY 26, 2021
Some moments in life are profoundly important. Perhaps you’ve saved carefully for years to take your family on a special vacation. Or perhaps you’ve just been given a life-changing diagnosis that’s left you in a state of shock. Whether positive or negative, in a moment that important, you’re living in an altered state. Things might seem overwhelming, with the world moving too fast for you to understand what’s going on; or you may freeze, and it may feel like reality has slowed to a crawl.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Drug Patent Watch
MAY 28, 2021
Annual Drug Patent Expirations for GOPRELTO Goprelto is a drug marketed by Genus Lifesciences and is included in one NDA. It is available from one supplier. There are nine patents…. The post New patent for Genus Lifesciences drug GOPRELTO appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
MAY 27, 2021
Concert Pharmaceuticals has started the second of two planned phase 3 trials of its drug candidate for alopecia areata (AA), a common cause of hair loss, and says it hopes to report results in the second half of 2022. The two studies – THRIVE-AA1 and THRIVE-AA2 – are testing oral JAK1/2 inhibitor CTP-543 in adults with moderate-to-severe AA, an autoimmune disease that leads to loss of hair in patches on scalp and body.
NY Times
MAY 25, 2021
Women often experience the hormonal transition of midlife in a shroud of misinformation and shame. We deserve better.
Pharma Times
MAY 26, 2021
Once-daily oral treatment was well-tolerated and demonstrated a good safety profile in Phase IIb study
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Patent Watch
MAY 27, 2021
Annual Drug Patent Expirations for KYLEENA Kyleena is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There are four patents…. The post New patent for Bayer Hlthcare drug KYLEENA appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
MAY 24, 2021
Takeda has revealed long-term clinical trial results with its dengue vaccine that reinforce its safety and efficacy – and help to differentiate it from Sanofi’s challenged Dengvaxia shot. Updated results from the large-scale TIDES trial of TAK-003 show that three years after dosing it was 62% effective at warding off dengue symptoms and prevented more than 83% of hospitalisations due to the viral infection in children aged four to 16.
Outsourcing Pharma
MAY 27, 2021
Sanofi and GSK have started the Phase 3 study for their COVID-19 vaccine candidate: eying up potential regulatory authorization in Q4, 2021.
Pharma Times
MAY 24, 2021
First targeted treatment authorised in the US for NSCLC patients with EGFR exon 20 insertion mutations
Drug Patent Watch
MAY 28, 2021
Annual Drug Patent Expirations for DOCETAXEL Docetaxel is a drug marketed by Accord Hlthcare, Actavis Llc, Amneal, Apotex Inc, Dfb Oncology Ltd, Dr Reddys Labs Ltd, Hikma, Hong Kong, Hospira…. The post New patent for Shilpa drug DOCETAXEL appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
MAY 27, 2021
Myovant has chalked up a second approval for its flagship drug relugolix from the FDA, becoming the first once-daily oral drug in the US to treat heavy menstrual bleeding associated with uterine fibroids. . The drug will be sold as Myfembree (relugolix) for the uterine fibroids indication, and is already available to treat prostate cancer under the Orgovyx brand name.
NY Times
MAY 28, 2021
The United States began vaccinating children in that age group earlier this month.
Pharma Times
MAY 24, 2021
At six and a half years 49% of patients treated with combination therapy remained alive
Drug Patent Watch
MAY 23, 2021
ZOMIG (zolmitriptan) Astrazeneca Patent: 7,220,767 Expiration: May 28, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit…. The post Drug Patent Expirations for the Week of May 23, 2021 appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
MAY 26, 2021
A UK tech firm with an NHS-commissioned mental health app – Hello Tomo – has been acquired by ICAS World, a company specialising in providing employee health and wellbeing services. . Hello Tomo is described as a behaviour change tool for mental health and wellbeing that aims to help users maintain healthy habits, and according to ICAS is the first of a series of acquisitions underpinning a new digital health strategy at the group.
Outsourcing Pharma
MAY 25, 2021
With the Engagement Solution Center, the patient-recruitment services specialist is aiming to improve the patient-centricity and inclusivity of studies.
Pharma Times
MAY 24, 2021
Collaboration will aim to address challenge of timely and costly AAV-based vector manufacturing
Drug Patent Watch
MAY 28, 2021
Annual Drug Patent Expirations for XADAGO Xadago is a drug marketed by Mdd Us and is included in one NDA. It is available from one supplier. There are three patents…. The post New patent for Mdd Us drug XADAGO appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
MAY 26, 2021
Belgium’s Ministry of Health has paused dosing of people under the age of 41 with Johnson & Johnson’s one-shot COVID-19 vaccine, following the death of a woman from what appeared to be a blood clot-related condition. . The unnamed woman – who was under the age of 40 – died on 21 May after being admitted to hospital with severe thrombosis and low blood platelets, according to a statement from the Interministerial Conference on Public Health (CIM), which brings together national an
NY Times
MAY 22, 2021
An inoculation push, plagued with limited supplies and red tape, makes doses available to those who can pay for them. In a country with a struggling economy, most can’t.
Pharma Times
MAY 28, 2021
In Phase III, adjuvant treatment with Tagrisso reduced the risk of disease recurrence or death by 80% in the overall population
Outsourcing Pharma
MAY 25, 2021
Acting FDA commissioner Janet Woodcock explains how government, researchers, doctors and patients can contribute to improving the clinical research system.
pharmaphorum
MAY 25, 2021
With the ink barely dry on the FDA’s approval of Johnson & Johnson’s Rybrevant, its first bispecific antibody for cancer, the drugmaker is already showcasing others in its pipeline. . Two of its earlier-stage bispecifics – both in development for the blood cancer multiple myeloma – will feature at the American Society of Clinical Oncology (ASCO) congress, which kicks off in a few days’ time.
NY Times
MAY 22, 2021
Mr. Hanly had been central to the current nationwide litigation against pharmaceutical companies, pharmacies and others in the opioid supply chain.
Pharma Times
MAY 27, 2021
Once-daily treatment has been approved for the management of heavy menstrual bleeding
Pharma Mirror
MAY 28, 2021
If you are trying to set up your own laboratory, then you should prepare for a myriad of expenses. Budgeting is a process that is required throughout the running of your lab. It keeps everything in order and ensures the continued efficiency of whatever operation or experiment you are overseeing. Without the proper financial backing, things may quickly fall apart soon after.
pharmaphorum
MAY 27, 2021
Ada Health has received another endorsement for its app to help patients diagnose conditions from symptoms, raising an impressive $90 million in funding from investors including the venture capital arm of Bayer. . Leaps by Bayer was joined by Samsung Catalyst Fund, Vitruvian Partners, Inteligo Bank, F4 and Mutschler Ventures in the second-round financing of the digital health player, whose app recently beat out the competition in a peer-review study published in the journal BMJ Open.
Drug Patent Watch
MAY 27, 2021
Annual Drug Patent Expirations for ZOMIG Zomig is a drug marketed by Astrazeneca and IPR and is included in three NDAs. It is available from one supplier. There are two…. The post New patent expiration for Astrazeneca drug ZOMIG appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Times
MAY 24, 2021
First one-time gene therapy for CALD among latest recommendations
Pharma Mirror
MAY 27, 2021
The second week of CPhI Discover is open amid news that both the Italian and French governments have confirmed they will allow trade shows to resume – providing formal confirmation for both CPhI Worldwide and Pharmapack Europe. The last year has seen pharma evolve its approach to meeting new partners and existing customers, with wider pools of suppliers now needed, and remote and virtual networking being used to begin conversations much earlier than in the past.
Expert insights. Personalized for you.
140 
Let's personalize your content